To achieve excellence, our policy has always been Customer oriented. To meet specific needs, we have established several industrial collaborations. LabAnalysis Group was born from the union of several companies that incorporates over 40 years of consolidated and matured experience. The synergy allows us to offer complementary, up-to-date and effective services, always looking beyond the customer's expectations.
In order to protect patients and users of certain products, it is necessary to design study to assess the interaction between the released or migrated components into the pharmaceutical product and the possible health risk to the user.
Nitrosamines represent one of the first risks of contamination in pharmaceutical products and basic active ingredients: listed as carcinogenic mutagens [...]
Starting from 27th of March 2021 Reg. EU No. 1381/2019 – Transparency Regulation influences all applications for Regulated Products authorization, including food and feed additives, novel foods, food enzymes, flavorings and GMOs.
An analysis conducted on the risk assessment allows companies and administrations to meet the increasingly high standards of safety in the FCM context. Indeed, [...]
Medicines must be tested for the presence of nitrosamines before being released into the European Market, stated European Medicines Agency (EMA).
LabAnalysis has developed [...]
We are proud to be one of the 78 companies that have been awarded Welfare Champion 2020 by WelfareIndexPMI for the enhancement of the well-being of our employees. The event wa [...]
Versalis, the chemical company of Eni Energies & Services, has distributed the hand sanitizer in all the Italian schools, to meet the growing demand caused by [...]
Food & Catering
Environmental Administrations
Chemistry and Related
Cosmetics
Cleansing Products
Circular Economy
Construction
Electricity, Gas and related industries
Third Party Laboratories
Food Supplements
Oil & Gas
Crop Production
Industrial Production
Recycling & Recovery
